Kris Sachsenmeier

Kris Sachsenmeier

Takeda Pharmaceutical Company Limited - Osaka / Japan
Others
AD Scientific Index ID: 4405804
武田薬品工業株式会社
person_outline Kris Sachsenmeier's MOST POPULAR ARTICLES
1-) Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responsesA Young, SF Ngiow, DS Barkauskas, E Sult, C Hay, SJ Blake, Q Huang, ...Cancer cell 30 (3), 391-403, 20162802016
2-) Targeting CD73 in the tumor microenvironment with MEDI9447CM Hay, E Sult, Q Huang, K Mulgrew, SR Fuhrmann, KA McGlinchey, ...Oncoimmunology 5 (8), e1208875, 20162842016
3-) A new bliss independence model to analyze drug combination dataW Zhao, K Sachsenmeier, L Zhang, E Sult, RE Hollingsworth, H YangJournal of biomolecular screening 19 (5), 817-821, 20142822014
4-) Arylamine N-Acetyltransferase-1 Is Highly Expressed in Breast Cancers and Conveys Enhanced Growth and Resistance to Etoposide in VitroPJ Adam, J Berry, JA Loader, KL Tyson, G Craggs, P Smith, J De Belin, ...Molecular cancer research 1 (11), 826-835, 20031442003
5-) Improving target cell specificity using a novel monovalent bispecific IgG designY Mazor, V Oganesyan, C Yang, A Hansen, J Wang, H Liu, ...MAbs 7 (2), 377-389, 20151352015